
1. front biosci. 1998 dec 1;3:d1192-208.

papillomavirus vaccines.

duggan-keen mf(1), brown md, stacey sn, stern pl.

author information: 
(1)paterson institute cancer research, christie hospital nhs trust,
manchester m20 4bx, united kingdom.

the considerable morbidity mortality associated certain human
papillomaviruses (hpv) provided impetus hpv vaccine development. 
design vaccines evolved understanding nature hpv
infections consequences, together evaluation efficacy of
different approaches vaccination animal models. studies have
culminated production several different vaccine preparations 
currently undergoing phase ii clinical trials. justification the
widespread implementation prophylactic hpv vaccines depend outcome
of larger scale studies vaccine efficacy take account the
epidemiology hpv infections associated disease. usefulness of
therapeutic hpv vaccines require evidence substantially
augment substitute effectiveness currently available treatments.

doi: 10.2741/a356 
pmid: 9835649  [indexed medline]

